ResMed Inc. (RME.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 09:00AM CEST
| Previous close | 168.00 |
| Open | 186.00 |
| Bid | 202.70 x 20000 |
| Ask | 204.20 x 20000 |
| Day's range | 186.00 - 190.05 |
| 52-week range | 126.40 - 218.20 |
| Volume | |
| Avg. volume | 25 |
| Market cap | 29.899B |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | 31.36 |
| EPS (TTM) | 6.06 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | 1.79 (0.94%) |
| Ex-dividend date | 08 May 2024 |
| 1y target est | 261.67 |
GuruFocus.comDecoding ResMed Inc (RMD): A Strategic SWOT Insight
Insightful Analysis of ResMed Inc's Financial Health and Strategic Position
Investor's Business DailyHow 'Megatrends' Like Weight-Loss Drugs And Smartwatches Are Bolstering ResMed
ResMed stock jumped Friday after crushing sales estimates and wiping out worries that weight-loss drugs would squeeze sleep apnea device sales.
ZacksInteger Holdings (ITGR) Q1 Earnings Top Estimates, Margins Up
Integer Holdings' (ITGR) first-quarter results reflect robust Medical Sales, along with strength in all the product lines.
© 2024 Yahoo. All rights reserved.